Kingdon Capital Management »

Haemonetics Corporation shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $10M 111k 89.58
2023-03-31 $4.1M 50k 82.75
2022-06-30 $6.2M 96k 65.18
2021-12-31 $18M 335k 53.04
2021-09-30 $14M 200k 70.59

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Blackstone Group Inc Com Cl A Put Option (BX)
Sherwin-Williams Company Call Option (SHW)
Api Group Corp Com Stk (APG)
Catalent (CTLT)
Rapt Therapeutics (RAPT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teck Resources CL B (TECK)
Meta Platforms Cl A (META)
Ftai Aviation SHS (FTAI)
Union Pacific Corporation (UNP)
Molson Coors Beverage CL B (TAP)
Synchrony Financial Put Option (SYF)
Bank of America Corporation Call Option (BAC)
Dell Technologies CL C (DELL)

View all positions for Kingdon Capital Management

Top funds holding Haemonetics Corporation

Vanguard Group
Neuberger Berman Group
Wellington Management Company
Franklin Resources
Royce & Associates
Dimensional Fund Advisors
Westfield Capital Management Company
Btim
Fisher Investments
Robeco Investment Management
Charles Schwab Investment Management
Bank of New York Mellon
Allspring Global Investments Holdings
T. Rowe Price Associates
Norges Bank Investment Management

View all funds holding Haemonetics Corporation